Emtreat Pharmaceuticals Private Limited
About Emtreat Pharmaceuticals Private Limited
Data last updated:
Emtreat Pharmaceuticals Private Limited is a private limited company based in Akola, Maharashtra, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 30 May 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85191MH2015PTC265085. Its GSTIN is 27AADCE9668A1ZJ (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Arun Omprakash Sharma (Managing Director) and Mangala Arun Sharma (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 43A Agrawal Layout Hanuman Nagar Lahan Umari, Akola, Maharashtra, India – 444005.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.2 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹5.8 Lakh (net margin 1.8%) and EBITDA of ₹13.03 Lakh (EBITDA margin 4.1%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 12% over five years.
The company has about 36 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Emtreat Pharmaceuticals Private Limited's registered office is in Akola, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address43A Agrawal Layout Hanuman Nagar Lahan Umari, Akola, Maharashtra, India – 444005
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Emtreat Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Emtreat Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Emtreat Pharmaceuticals Private Limited, buy the company report.
Financials of Emtreat Pharmaceuticals Private Limited
FY 2025 filings availableEmtreat Pharmaceuticals Private Limited reported revenue of ₹3.2 Cr (up 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 20% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.03 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.8 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.1% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Emtreat Pharmaceuticals Private Limited, buy the company report.
Board of directors of Emtreat Pharmaceuticals Private Limited
Emtreat Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mangala Arun Sharma | Whole-Time Director | 30 May 2015 | 11 Years 5 Months | Current |
| Arun Omprakash Sharma | Managing Director | 30 May 2015 | 11 Years 5 Months | Current |
Auditor
Emtreat Pharmaceuticals Private Limited is audited by AGRAWALGOYALJAIN & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGRAWALGOYALJAIN & ASSOCIATES | FY 2017 | 133660W |
Shareholding
The shareholding of Emtreat Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Emtreat Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Emtreat Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Emtreat Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Emtreat Pharmaceuticals Private Limited has a workforce of 36 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Emtreat Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCE9668A1ZJ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Emtreat Pharmaceuticals Private Limited, buy the company report.
Recent activity
Emtreat Pharmaceuticals Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Arun Omprakash Sharma ceased to be Director on 31 Dec 2016.
Frequently asked questions
Emtreat Pharmaceuticals is an active private limited company based in Akola, Maharashtra, India. The company works in wholesale, within the trading industry. It was incorporated on 30 May 2015 (11+ years old) and is registered under CIN U85191MH2015PTC265085.
Emtreat Pharmaceuticals has 2 current directors:
- Arun Omprakash Sharma - Managing Director
- Mangala Arun Sharma - Whole-Time Director
The latest financial statements of Emtreat Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Emtreat Pharmaceuticals is 27AADCE9668A1ZJ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Emtreat Pharmaceuticals is U85191MH2015PTC265085. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Emtreat Pharmaceuticals was incorporated on 30 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
Arun Omprakash Sharma ceased to be Director on 31 Dec 2016. Mangala Arun Sharma ceased to be Director on 31 Dec 2016. Arun Omprakash Sharma was appointed as Managing Director on 30 May 2015. Emtreat Pharmaceuticals has 4 board changes on record in total.
The registered office of Emtreat Pharmaceuticals is at 43A Agrawal Layout Hanuman Nagar Lahan Umari, Akola, Maharashtra, India – 444005.
Emtreat Pharmaceuticals operates in the trading industry, in the wholesale segment.
The compliance status of Emtreat Pharmaceuticals is compliant as of 24 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
